MedTrace Logo

Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer

NCT00947102 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2010-01-13

No results posted yet for this study

Summary

Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.

Conditions

  • Pancreatic Tubular Adenocarcinoma

Interventions

OTHER

Observation

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    collaborator OTHER

  • Blood Transfusion Centre of Slovenia

    lead OTHER_GOV

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947102 on ClinicalTrials.gov